---
name: SSRI Thiazide with low sodium concentration

data:
-
	resourceType: Patient
	name: Fuller Jackson
	gender: male
	birthDate: 1954-02-16
-
	resourceType: MedicationStatement
	code: RXNORM#794947 Sertraline 150 MG Oral Tablet
	effectiveDateTime: 2019-07-30T00:00:00.000+00:00
-
	resourceType: MedicationStatement
	code: RXNORM#197499 Chlorthalidone 25 MG Oral Tablet
	effectiveDateTime: 2019-08-31T00:00:00.000+00:00
-
	resourceType: Observation
	code: LOINC#2947-0 Sodium [Moles/volume] in Blood
	valueQuantity: 120 mmol/L
	issued: 2019-09-15T00:00:00.000+00:00
-
	resourceType: Observation
	code: LOINC#2947-0 Sodium [Moles/volume] in Blood
	valueQuantity: 115 mmol/L
	issued: 2019-09-12T00:00:00.000+00:00

results:
	Summary:
		Patient:
			Name: Fuller Jackson
			Gender: male
			Age: 65
		HistoricalTreatments:
			SSRIsSNRIs:
			-
				Type: Statement
				Name: Sertraline 150 MG Oral Tablet
				Start: '2019-07-30T00:00:00.000+00:00'
				End: null
				Status: active
			Thiazides:
			-
				Type: Statement
				Name: Chlorthalidone 25 MG Oral Tablet
				Start: '2019-08-31T00:00:00.000+00:00'
				End: null
				Status: active
			HighestSodiumConcentration:
			-
				Name: Sodium [Moles/volume] in Blood
				Result: 120 mmol/L
				Date: '2019-09-15T00:00:00.000+00:00'
		GeneralRiskFactors:
			Is65orOlder: true
			IsFemale: false
		RiskFactorsForHyponatremia:
			MedicationRiskFactors: null
			ConditionRiskFactors: null
		Alert:
			Recommendation: 'Avoid concurrent if possible. If combination is used, monitor serum sodium'
			Rationale: 'Substantial risk of hyponatremia'
			Classification: 'Avoid Combination'
			Indicator: 'critical'
